Life Science

In Vitro Diagnostics (IVD) in Malaysia, Singapore and Indonesia, 2022

In Vitro Diagnostics (IVD) in Malaysia, Singapore and Indonesia, 2022

Regular price $6,000.00 USD
Regular price Sale price $6,000.00 USD
Sale Sold out
Published Date
Length Pages
SKU

In Vitro Diagnostics (IVD) in Malaysia, Singapore and Indonesia, 2022

The Asia Pacific (APAC) region is a fast-growing in vitro diagnostics (IVD) market, which is witnessing increasing focus by leading global players in the market. Southeast Asia has been identified as one of the key regions in APAC region offering significant opportunities for IVD companies.

This report focuses on three IVD markets in Southeast Asia: Malaysia, Indonesia, and Singapore. These three countries together represent a fast-growing geographic region offering significant opportunity for IVD companies. The total population of these three countries is over 310 million, which is close to the population in the United States.

Among these three countries, Singapore has established world class healthcare service capabilities in terms of infrastructure as well as skilled manpower. Though the population is less than 6 million, the Singapore market is attractive for IVD companies and it has become a medical tourism hub in the region. Indonesia, on the other hand, is a country with a huge population of about 275 million people. The country is taking significant steps to improve its healthcare infrastructure, which is offering considerable opportunities for IVD companies. The Malaysian market, with a population of about 32 million falls in between these two countries, both in terms of healthcare service capabilities and growth potentials.

In Vitro Diagnostics (IVD) in Malaysia, Singapore, and Indonesia, 2022 covers the following segments:POCClinical ChemistryImmunoassaysMolecular AssaysHematologyCoagulationMicrobiology and VirologyBlood Testing and TypingHistology and CytologyThe report also profiles key companies in the market:Abbott DiagnosticsARKRAYBeckman Coulter, Inc. / DanaherBecton, Dickinson, and Company (BD)BioCytech CorporationbioMérieux Inc.Bio-Rad Laboratories, Inc.Caris Life SciencesCepheiCTK Biotech IncDanaher CorporationDexcomDiaSorin S.p.AGrifols S.A.Healgen Scientific LLCHologic, Inc.Horiba MedicalLucence DiagnosticsMedical Innovation Ventures Sdn. Bhd. (Mediven)Mindray (Shenzhen Mindray Bio-medical Electronics Co., Ltd.)MiRXES Pte Ltd.OraSure Technologies, Inc.Ortho Clinical Diagnostics (Ortho)PerkinElmer, Inc. (PE)QIAGENReszon Diagnostics InternationalRoche DiagnosticsSysmex CorporationVela DiagnosticsVeredus Laboratories Pte Ltd

View full details